Aller au contenu principal
Profil bibliographique

Isabel Hubbard

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
976Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Amyotrophic Lateral Sclerosis ResearchAcute Ischemic Stroke ManagementRNA Research and SplicingAlzheimer's disease research and treatmentsEpilepsy research and treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Glial cell toxicity in a Drosophila C9orf72 neurodegeneration model

Isabel Hubbard, Josh Dubnau

The most common genetic cause of both familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an expanded G4C2 repeat in the first intron of the gene C9orf72. The C9orf72 repeat expansion is bidirectionally transcribed into sense and anti-sense RNA foci, …

us (code pays fourni par la source)

0 citations PLoS Genetics
Accès ouvert 2026 dataset OpenAlex

Glial toxicity in a Drosophila C9orf72 neurodegeneration model

Isabel Hubbard, Josh Dubnau

The most common genetic cause of both familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an expanded G4C2 repeat in the first intron of the gene C9orf72. The C9orf72 repeat expansion is bidirectionally transcribed into sense and anti-sense RNA foci, …

us (code pays fourni par la source)

0 citations DRYAD
Accès ouvert 2025 preprint OpenAlex

Glial cell-intrinsic and non-cell autonomous toxicity in a Drosophila C9orf72 neurodegeneration model

Isabel Hubbard, Josh Dubnau

Abstract The most common genetic cause of both familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an expanded G 4 C 2 repeat in the first intron of the gene C9orf72. The C9orf72 repeat expansion is bidirectionally transcribed into sense …

us (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2023 article OpenAlex

TDP-43 pathology in Drosophila induces glial-cell type specific toxicity that can be ameliorated by knock-down of SF2/SRSF1

Sarah Krupp, Isabel Hubbard, Oliver H. Tam, Molly Hammell et autres

Accumulation of cytoplasmic inclusions of TAR-DNA binding protein 43 (TDP-43) is seen in both neurons and glia in a range of neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Alzheimer's disease (AD). Disease progression involves non-cell autonomous interactions among …

us (code pays fourni par la source)

4 citations PLoS Genetics
Accès ouvert 2021 article OpenAlex

International Practice Recommendations for the Recognition and Management of Hearing and Vision Impairment in People with Dementia

Jenna Louise Littlejohn, Michael A. Bowen, Fofi Constantinidou, Piers Dawes et autres

INTRODUCTION: Hearing, vision, and cognitive impairment commonly co-occur in older people. However, the rate of recognition and appropriate management of combined hearing and vision impairment in people with dementia impairment is low. The aim of this work was to codevelop internationally relevant, …

gb, cy, au, us, ca, ie (code pays fourni par la source)

53 citations Gerontology
Accès ouvert 2020 article OpenAlex

Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia

Mercedes Prudencio, Jack Humphrey, Sarah R. Pickles, Anna‐Leigh Brown et autres

No treatment for frontotemporal dementia (FTD), the second most common type of early-onset dementia, is available, but therapeutics are being investigated to target the 2 main proteins associated with FTD pathological subtypes: TDP-43 (FTLD-TDP) and tau (FTLD-tau). Testing potential therapies in clinical …

us, gb (code pays fourni par la source)

265 citations Journal of Clinical Investigation
Accès ouvert 2019 article OpenAlex

Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia

Oliver H. Tam, Nikolay V. Rozhkov, Regina Shaw, Duyang Kim et autres

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. While several pathogenic mutations have been identified, the vast majority of ALS cases have no family history of disease. Thus, for most ALS cases, the …

us (code pays fourni par la source)

348 citations Cell Reports
Accès ouvert 2019 preprint OpenAlex

Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia

Oliver H. Tam, Nikolay V. Rozhkov, Regina Shaw, Duyang Kim et autres

Summary Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. While several inherited pathogenic mutations have been identified as causative, the vast majority of cases are sporadic with no family history of disease. Thus, …

us (code pays fourni par la source)

25 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2018 article OpenAlex

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism

Erin G. Conlon, Delphine Fagegaltier, Phaedra Agius, Julia Davis‐Porada et autres

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent two ends of a disease spectrum with shared clinical, genetic and pathological features. These include near ubiquitous pathological inclusions of the RNA-binding protein (RBP) TDP-43, and often the presence of a GGGGCC expansion …

us, nl, gb, gr, il (code pays fourni par la source)

89 citations eLife
Accès ouvert 2018 article OpenAlex

Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia

Miguel Santos‐Santos, Gil D. Rabinovici, Leonardo Iaccarino, Nagehan Ayakta et autres

Importance: The ability to predict the pathology underlying different neurodegenerative syndromes is of critical importance owing to the advent of molecule-specific therapies. Objective: To determine the rates of positron emission tomography (PET) amyloid positivity in the main clinical variants of primary progressive …

es, us, it, kr (code pays fourni par la source)

107 citations JAMA Neurology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.